| JABRX | RLBEX | JABRX / RLBEX | |
| Total Expense Ratio | 1.07 | 0.59 | 181% |
| Annual Report Gross Expense Ratio | 1.07 | 0.59 | 181% |
| Fund Existence | 16 years | 24 years | - |
| Gain YTD | 7.574 | 10.716 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 28.5B | 269B | 11% |
| Annual Yield % from dividends | 1.35 | 1.68 | 80% |
| Returns for 1 year | 5.88 | 9.12 | 64% |
| Returns for 3 years | 35.67 | 38.04 | 94% |
| Returns for 5 years | 27.11 | 34.74 | 78% |
| Returns for 10 years | 89.36 | 75.41 | 119% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AMID | 34.30 | N/A | +0.01% |
| Argent Mid Cap ETF | |||
| FLYU | 58.49 | N/A | N/A |
| MicroSectors™ Travel 3X Leveraged ETNs | |||
| UCON | 25.17 | -0.01 | -0.04% |
| First Trust Smith Unconstrained Pl BdETF | |||
| DIAL | 18.48 | -0.03 | -0.16% |
| Columbia Diversified Fixed Inc Allc ETF | |||
| LFSC | 38.87 | -0.40 | -1.03% |
| F/m Emerald Life Sciences Innovation ETF | |||